Natus Medical Incorporated
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NTUS research report →
Companywww.natus.com
Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and technologies used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories.
- CEO
- Jonathan Kennedy
- IPO
- 2001
- Employees
- 1,400
- HQ
- Pleasanton, CA, US
Price Chart
Valuation
- Market Cap
- $0
- P/E
- 84.98
- P/S
- 0.00
- P/B
- 2.64
- EV/EBITDA
- -1.30
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 57.81%
- Op Margin
- 4.48%
- Net Margin
- 2.78%
- ROE
- 3.15%
- ROIC
- 3.18%
Growth & Income
- Revenue
- $473.44M · 13.89%
- Net Income
- $13.18M · 179.32%
- EPS
- $0.39 · 179.59%
- Op Income
- $21.23M
- FCF YoY
- 133.86%
Performance & Tape
- 52W High
- $33.93
- 52W Low
- $20.90
- 50D MA
- $32.61
- 200D MA
- $27.38
- Beta
- 0.23
- Avg Volume
- 339.69K
Get TickerSpark's AI analysis on NTUS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 21, 22 | LEVINE JOSHUA | sell | 37,387 |
| Jul 21, 22 | Heine Lisa Wipperman | sell | 26,287 |
| Jul 21, 22 | Sullivan Thomas Joseph | other | 648,554 |
| Jul 21, 22 | Sullivan Thomas Joseph | sell | 720,903 |
| Jul 21, 22 | Noll Austin Francis III | other | 61,966 |
| Jul 21, 22 | Noll Austin Francis III | sell | 72,534 |
| Jul 21, 22 | Noll Austin Francis III | sell | 200,509 |
| Jul 21, 22 | CHUNG DONG CHUNE CHRISTOPHER | other | 35,056 |
| Jul 21, 22 | CHUNG DONG CHUNE CHRISTOPHER | sell | 83,374 |
| Jul 21, 22 | CHUNG DONG CHUNE CHRISTOPHER | sell | 35,360 |
Our NTUS Coverage
We haven't published any research on NTUS yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate NTUS Report →